8-KLeadership Changes

REGENERON PHARMACEUTICALS, INC. 8-K Report, Executive Changes (Nov 13, 2015)

Filed November 13, 2015For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on November 13, 2015, to report a change in its Board of Directors. Robert A. Ingram resigned from his position as a Director and member of the Compensation Committee, effective November 10, 2015. The company stated that Mr. Ingram's resignation was due to demands from his other business activities and not a result of any disagreement with Regeneron's operations, policies, or practices.

Key Highlights

  • 1Robert A. Ingram has resigned from Regeneron's Board of Directors.
  • 2Mr. Ingram also resigned from the Compensation Committee of the Board.
  • 3The resignation was effective November 10, 2015.
  • 4The reason cited for resignation is increased demands from other business activities.
  • 5Regeneron stated there were no disagreements with Mr. Ingram regarding the company's operations, policies, or practices.

Frequently Asked Questions